Published in

Springer Nature [academic journals on nature.com], Leukemia, 7(27), p. 1615-1616, 2013

DOI: 10.1038/leu.2013.146

Springer Nature [academic journals on nature.com], Leukemia, 6(26), p. 1419-1422, 2011

DOI: 10.1038/leu.2011.352

Links

Tools

Export citation

Search in Google Scholar

Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case—control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Multiple myeloma (MM) is a hematological neoplasm that arises from a single clone of malignant plasma cells in the bone marrow. In Europe, 4.6/100 000 males and 3.2/100 000 females every year develop MM, with a median age at diagnosis around 60 years. ; Consejería de Salud de la Junta de Andalucia (Sevilla, Spain) - P08-CVI-4116 ; Fondo de Investigaciones Sanitarias (Madrid, Spain) - PI081051 ; Polish Ministry of Science and Higher Education (Lodz, Poland) - NN40217833